| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Therapy: Clinical |
Authors' Affiliations: 1 Department of ORL, Academic Medical Center, and Departments of 2 Pathology, 3 Head and Neck Oncology, 4 Radiotherapy, 5 Pulmonology, and 6 Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands
Requests for reprints: Marie-Louise F. van Velthuysen, Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Phone: 31-20-5122750; Fax: 31-20-5122759; E-mail: m.v.velthuysen{at}nki.nl.
Purpose: To distinguish a metastasis from a second primary tumor in patients with a history of head and neck squamous cell carcinoma and subsequent pulmonary squamous cell carcinoma.
Experimental Design: For 44 patients with a primary squamous cell carcinoma of the head and neck followed by a squamous cell carcinoma of the lung, clinical data, histology, and analysis of loss of heterozygosity (LOH) were used to differentiate metastases from second primary tumors.
Results: Clinical evaluation suggested 38 patients with metastases and 6 with second primaries. We developed a novel interpretation strategy based on biological insight and on our observation that multiple LOH on different chromosome arms are not independent. LOH analysis indicated metastatic disease in 19 cases and second primary squamous cell carcinoma in 24 cases. In one case, LOH analysis was inconclusive. For 25 patients, LOH supported the clinical scoring, and in 18 cases, it did not. These 18 discordant cases were all considered to be second primary tumors by LOH analysis.
Conclusions: A considerable number of squamous cell lung lesions (50% in this study), clinically interpreted as metastases, are suggested to be second primaries by LOH analysis. For these patients, a surgical approach with curative intent may be justified.
This article has been cited by other articles:
|
|
 |
|
  T.W. Geurts, M.L.F van Velthuysen, F. Broekman, T. Hooft van Huysduynen, M.W.M. van den Brekel, N. van Zandwijk, H. van Tinteren, P. Nederlof, A.J.M. Balm, and R.H. Brakenhoff Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis Clin. Cancer Res., February 1, 2009; 15(3): 980 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Winter, G. Meimarakis, G. Hoffmann, M. Hummel, D. Ruttinger, A. Zilbauer, K. Stelter, F. Spelsberg, K.-W. Jauch, R. Hatz, et al. Does Surgical Resection of Pulmonary Metastases of Head and Neck Cancer Improve Survival? Ann. Surg. Oncol., October 1, 2008; 15(10): 2915 - 2926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-B. Hsu, P.-Y. Chu, J.-C. Liu, M.-C. Lan, S.-Y. Chang, T.-L. Tsai, J.-L. Huang, Y.-F. Wang, and S.-K. Tai Role of Chest Computed Tomography in Head and Neck Cancer Arch Otolaryngol Head Neck Surg, October 1, 2008; 134(10): 1050 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Furak, I. Trojan, T. Szoke, A. Wolfard, E. Nagy, I. Nemeth, L. Tiszlavicz, and G. Lazar Lung cancer as a second primary malignant tumor: prognostic values after surgical resection Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 50 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vachani, M. Nebozhyn, S. Singhal, L. Alila, E. Wakeam, R. Muschel, C. A. Powell, P. Gaffney, B. Singh, M. S. Brose, et al. A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma Clin. Cancer Res., May 15, 2007; 13(10): 2905 - 2915. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
